Bill

Bill > H4034


MA H4034

Relative to insulin access


summary

Introduced
07/29/2021
In Committee
07/29/2021
Crossed Over
Passed
Dead
12/31/2022

Introduced Session

192nd General Court

Bill Summary

Relative to insulin access. Financial Services.

AI Summary

This bill aims to improve access to insulin by capping the out-of-pocket cost for a 30-day supply at $100, regardless of the amount or type of insulin needed. It requires state-regulated health plans, including those under the Group Insurance Commission, Medicaid, and private insurers, to implement this cost cap. The bill also mandates that insulin manufacturers provide a one-time, 30-day supply of insulin at no cost to individuals who urgently need it and meet certain financial eligibility criteria. This is intended to help those who may be rationing insulin due to high costs.

Committee Categories

Business and Industry

Sponsors (20)

Last Action

Accompanied a study order, see H5209 (on 09/12/2022)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...